BioMarin Announces Proposed Private Offering of $500 Million of Senior Subordinated Convertible Notes

SAN RAFAEL, CA (STL.News) BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that it intends to offer,…

BioMarin to Host Third Quarter 2019 Financial Results Conference Call and Webcast on Wednesday, October 23 at 4:30pm ET

San Rafael, Calif., (STL.News) –  BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman…